News
LEXINGTON, Ky. (Aug. 25, 2020) 鈥 Research looking at a possible new therapeutic approach for Alzheimer鈥檚 disease was recently published in the Journal of Neuroinflammation.
The Lexington Walk to End Alzheimer's is Saturday, September 12th so wear purple, get out & walk around town!
To join our team, click here!
The COVID-19 pandemic has impacted research, outcomes, long-term care and disparities related to Alzheimer鈥檚 disease and other dementias, according to presenters at the Alzheimer鈥檚 Association International Conference 2020.
Regarding its effects on research, Gregory Jicha, MD, PhD, chair of the Alzheimer鈥檚 Association Clinical Trials Advancement and Methods professional interest area, highlighted steps to safely conduct Alzheimer鈥檚 disease-related studies in the current pandemic environment.
Complete the Race anytime between Friday, August 14 and Saturday, August 29, 2020 for the Virtual Morning Light 5k to help raise money for UK Sanders-Brown Center on Aging!
Race fee includes race t-shirt. Medals will be awarded for top performers in each age category.
$25 for Early Bird registration until July 31st.
$30 for registration starting August 1st.
To register, click here.
LEXINGTON, Ky. (July 30, 2020) 鈥擳he COVID-19 pandemic brought many things to a screeching halt and continues to impact our daily lives. However, important research at the University of Kentucky鈥檚 Sanders-Brown Center on Aging (SBCoA) is continuing under extreme caution and deep dedication.
鈥淚t can鈥檛 wait,鈥 said Dr. Greg Jicha, a neurologist at SBCoA.
LEXINGTON, Ky. (July 29, 2020) 鈥 Alzheimer鈥檚 disease (AD) is the most common form of dementia among the elderly and currently there is no cure for the disease. The hallmarks of AD are the A尾 plaques and tau tangles found throughout the patient鈥檚 brain. For the past several decades, much of the work to find a treatment for AD has been focused on eliminating those dreaded A尾 plaques, by assuming that memory could be restored by removing the plaques.
LEXINGTON, Ky. (July 17, 2020) 鈥 Researchers at the University of Kentucky Sanders-Brown Center on Aging (SBCoA) recently screened the first participant in the world for what is known as the AHEAD 3-45 study. This work is looking at a study medication, BAN2401, to determine if it can help prevent worsening memory and thinking among individuals who might be at risk for future decline. They are hoping this study finds that BAN2401 does just that and will ultimately help prevent Alzheimer鈥檚 disease.
LEXINGTON, Ky. (July 8, 2020) - A grant recently received by Maj-Linda B. Selenica, assistant professor at the University of Kentucky鈥檚 Sanders-Brown Center on Aging (SBCoA), is helping further collaborative research efforts. The $125,000 grant comes from The CART Fund. CART (Coins for Alzheimer鈥檚 Research Trust) is a grassroots effort by Rotary Club members throughout the country to provide cutting edge research to help find a cure for Alzheimer鈥檚.
The University of Kentucky鈥檚 Sanders-Brown Center on Aging has been a leader in Alzheimer鈥檚 Disease related research for many years. The success seen at Sanders-Brown can be directly attributed to the people within the center.
鈥淯K is fantastic at many things, but when it comes to driving the science and the search for cures for diseases like Alzheimer鈥檚, we are second to none,鈥 said Dr. Greg Jicha.
Linda J. Van Eldik, director of the Sanders-Brown Center on Aging at the University of Kentucky, co-authored a paper reporting the first human clinical study of a drug candidate that suppresses injury and disease-induced inflammation of the brain.
An international group of experts led by Dr. Peter Nelson, a neuropathologist at the University of Kentucky Sanders-Brown Center on Aging, is being recognized as one of the top science stories of 2019 by Discover Magazine.
More than 70,000 Kentuckians are living with Alzheimer's disease, which likely means that you know someone whose life has been touched 鈥 directly or indirectly 鈥 by dementia. And since that number is expected to rise to more than 85,000 in the next five years or so, Alzheimer's will likely hit closer to home for many of us.
At the University of Kentucky, multiple innovative biospecimen resources are available to assist research. A video produced by the UK Center for Clinical and Translational Science (CCTS) highlights the biospecimen resources offered by the CCTS, the UK Markey Cancer Center, the UK Gill Heart Institute, and the Alzheimer鈥檚 Disease Center at the Sanders-Brown Center on Aging.
A couple dozen bikers raised about $3,000 on Saturday during the fifth annual Alzheimer鈥檚 Ride for a Cure.
Arriving at the Sheriff鈥檚 Posse facility on Witty Lane, the route had not yet been released, and the bikers gathered in a small group to hear the directions of where they鈥檇 be headed.
First, they were going to Princeton, where they鈥檇 hang a left and work their way over to Land Between the Lakes for a stop at the welcome center on the Woodlands Trace National Scenic Byway, commonly referred to as just 鈥淭he Trace.鈥
LEXINGTON, Ky. (Sept. 1, 2016) 鈥擳he University of Kentucky Sanders-Brown Center on Aging Alzheimer's Disease Center (ADC) has been awarded an $8.25 million, five-year grant from the National Institutes of Health (NIH) to continue and further research and clinical initiatives geared toward treating Alzheimer's disease.
LEXINGTON, Ky. (Oct. 3, 2016) 鈥 Because Alzheimer鈥檚 disease (AD) is the leading cause of dementia, many people use the two terms interchangeably. But inadequate blood flow to the brain due to microinfarcts, mini-strokes, or strokes is a hallmark of a disease called Vascular Cognitive Impairment and Dementia (VCID). VCID is the second most common cause of dementia, and the two are not mutually exclusive 鈥 researchers estimate that 40-60% of Alzheimer鈥檚 disease patients also have VCID.
The University of Kentucky Sanders-Brown Center on Aging will hold the 9th Annual Markesbery Symposium on Aging and Dementia on Wednesday, Nov. 6. The scientific session opens with check-in and registration at 8:15 am in Karpf Auditorium, Pavilion A, UK Chandler Hospital 1000 S. Limestone. Speaker presentations begin at 9:30 a.m. and end at noon.
Judged poster session and boxed lunch will be held from 12:15 鈥 2:30 p.m. in the atrium of the Biomedical/Biological Sciences Research Building (BBSRB) 741 S. Limestone.